Ractopamine is an animal feed additive used to promote leanness and increase food conversion efficiency in farmed animals in few countries, banned in most. Pharmacologically, it is a phenol-based TAAR1 agonist and β adrenoreceptor agonist that stimulates adenylate cyclase activity and raises intracellular cyclic AMP in muscle and adipose tissues, shifting nutrient partitioning toward increased protein accretion and reduced fat deposition. It is typically formulated and dosed as the hydrochloride salt for swine, cattle or turkeys, is administered in feed over a defined withdrawal window, and is subject to hepatic and extrahepatic metabolism including phase II conjugation and oxidative pathways. Ractopamine is usually manufactured and supplied as a racemic mixture; its action profile, residues, and pharmacokinetics are dose, species and formulation dependent and are controlled by regulatory maximum residue limits where it is permitted.
Parent: Ractopamine
Parent: Ractopamine
Parent: Ractopamine
Parent: Ractopamine
Commercial ractopamine hydrochloride batches are produced to typical technical specifications that prioritize assay purity and control of related substances and residuals. Typical quality targets include assay 98.0 percent or greater for the active moiety, water content below about 1.0 percent, individual related impurities generally below 0.5 percent each and total related substances below about 2.0 percent. Common related compounds and impurities encountered during synthesis and storage include positional and stereoisomers, N-dealkylated derivatives, N-oxide species, phenolic oxidation products and simple condensation byproducts, plus counterion forms and salt-related species. Residual solvents are controlled to standard limits for Class 2 solvents for small organic alcohols (for example methanol in the low thousands of ppm), and heavy metals are controlled to parts-per-million levels consistent with good manufacturing practice. Identification and quantification are routinely performed by HPLC-UV and LC-MS for related substances, GC for residual solvents and ICP-MS for elemental impurities.
Ractopamine is used as a feed additive to promote lean muscle growth and improve feed conversion efficiency in certain food-animal production systems; it acts via β adrenoreceptor and TAAR1 pathways to increase protein deposition and reduce fat when administered to permitted species under labeled conditions.
Several major markets prohibit its use or effectively ban imports containing residues, including the European Union, China, Russia and Taiwan; many other countries also restrict or prohibit ractopamine. Approval and import tolerance policies vary by jurisdiction and are periodically updated by authorities.
Ractopamine is also encountered as ractopamine hydrochloride and under trade names such as Paylean for swine and Optaflexx for cattle, among other manufacturer designations.
No. Use of ractopamine in the United States is permitted but not universal. Some producers and processors do not use it and market ractopamine-free pork, while other operations may use ractopamine under label directions; residue testing and regulatory limits apply where it is used.
